Rockwell Medical affirms FY2026 sales guidance $70M–$75M
Rockwell Medical (NASDAQ: RMTI) affirms FY2026 sales guidance of $70.000M–$75.000M, unchanged, versus a $72.469M estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.